ARWR Arrowhead Pharmaceuticals

65.55
0.39
(-0.58%)

Arrowhead Pharmaceuticals ARWR 生物技術:藥物製劑

65.55
0.39
(-0.58%)
單位:美金千元
科目 2025/Q3 2025/Q2 2025/Q1 2024/Q4 2024/Q3 2024/Q2 2024/Q1 2023/Q4 2023/Q3 2023/Q2 2023/Q1 2022/Q4 2022/Q3 2022/Q2 2022/Q1 2021/Q4 2021/Q3 2021/Q2 2021/Q1 2020/Q4
營業收入淨額
256,472 27,767 542,709 2,500 - - - 3,551 16,097 15,825 146,267 62,546 31,575 32,412 151,805 27,439 38,283 45,891 32,810 21,303
營業成本
- - - - - - - - - - - - - - - - - - - -
營業毛利
256,472 27,767 542,709 2,500 - - - 3,551 16,097 15,825 146,267 62,546 31,575 32,412 151,805 27,439 38,283 45,891 32,810 21,303
營業費用
212,366 193,317 - 163,912 162,203 176,141 126,191 140,096 124,427 118,528 98,102 104,680 115,405 105,321 110,252 90,760 103,166 77,759 61,041 45,357
研發費用
174,687 162,368 133,102 137,002 135,826 152,431 101,122 116,491 99,855 94,757 74,881 83,695 83,377 72,180 75,985 65,765 65,766 59,325 44,696 36,555
推銷及管理費用
37,679 30,949 28,405 26,910 26,377 23,710 25,069 23,605 24,572 23,771 23,221 20,985 32,028 33,141 34,267 24,995 37,400 18,434 16,345 8,802
非經常性項目費用
- - - - - - - - - - - - - - - - - - - -
其他營業費用
- - - - - - - - - - - - - - - - - - - -
營業利益
44,106 -165,550 381,202 -161,412 -162,203 -176,141 -126,191 -136,545 -108,330 -102,703 48,165 -42,134 -83,830 -72,909 41,553 -63,321 -64,883 -31,868 -28,231 -24,054
其他收入及費用
13,709 10,843 10,053 7,943 4,052 7,258 6,439 3,223 4,602 4,478 4,568 507 1,673 863 3,969 449 -4,609 1,944 1,413 1,153
利息費用
21,694 24,382 21,639 21,646 14,647 5,094 7,244 5,367 5,262 5,158 5,057 - - - - - - - - -
稅前純益
36,121 -179,089 369,616 -175,115 -172,798 -173,977 -126,996 -138,689 -108,990 -103,383 47,676 -41,794 -82,157 -72,046 44,366 -62,872 -63,372 -29,924 -26,818 -20,732
所得稅
20,000 -437 1,753 103 546 - - -3,313 2,025 742 - 17 3,785 - - - 2 - - -
稅後純益
-23,750 -175,241 370,445 -173,085 -170,536 -170,793 -125,300 -132,864 -109,679 -102,946 48,675 -41,325 -85,511 -72,046 44,366 -62,872 -63,374 -29,924 -26,818 -20,732
基本每股稅後盈餘(元)
-0.14 -1.26 2.78 -1.39 -1.36 -1.38 -1.02 -1.24 - -0.96 0.46 -0.39 -0.81 -0.68 0.42 -0.6 - -0.29 -0.26 -0.2
稀釋每股稅後盈餘(元)
-0.18 -1.35 2.91 -1.39 -1.37 -1.39 -1 -1.24 -1.02 -0.97 0.46 -0.39 -0.81 -0.68 0.42 -0.6 -0.61 -0.29 -0.26 -0.2
基本平均股數(千股)
137,782 139,039 133,363 124,848 124,237 124,199 123,285 107,415 - 107,004 106,757 106,039 105,885 105,753 105,545 104,534 - 104,099 103,867 102,757
稀釋平均股數(千股)
136,661 139,039 134,484 124,848 124,237 124,199 123,285 107,415 - 107,004 108,143 106,039 105,885 105,753 107,929 104,534 - 104,099 103,867 102,757
還原基本每股稅後盈餘(元)
-0.14 -1.26 2.78 -1.39 -1.36 -1.38 -1.02 -1.24 - -0.96 0.46 -0.39 -0.81 -0.68 0.42 -0.6 - -0.29 -0.26 -0.2
還原稀釋每股稅後盈餘(元)
-0.18 -1.35 2.91 -1.39 -1.37 -1.39 -1 -1.24 -1.02 -0.97 0.46 -0.39 -0.81 -0.68 0.42 -0.6 -0.61 -0.29 -0.26 -0.2
還原基本平均股數(千股)
137,782 139,039 133,363 124,848 124,237 124,199 123,285 107,415 - 107,004 106,757 106,039 105,885 105,753 105,545 104,534 - 104,099 103,867 102,757
還原稀釋平均股數(千股)
136,661 139,039 134,484 124,848 124,237 124,199 123,285 107,415 - 107,004 108,143 106,039 105,885 105,753 107,929 104,534 - 104,099 103,867 102,757
EBITDA(千元)
23,086 -146,830 402,837 -151,805 -161,448 -153,927 -111,800 -127,382 -99,520 -94,718 55,629 -37,929 -78,169 -67,768 47,569 -60,579 -60,744 -27,978 -24,405 -19,186

目前沒有任何討論